Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease multiple endocrine neoplasia type 1
Comorbidity C0007134|renal cell carcinoma
Sentences 2
PubMedID- 23924450 Evaluation of efficacy and safety of sunitinib regimen in 22 patients with metastatic renal cell carcinoma: at least 12-month follow-up.
PubMedID- 22013228 This study assessed the response rates and toxicity profiles of sunitinib on a continuous once-daily dosing regimen in turkish patients with metastatic renal cell carcinoma.

Page: 1